Fig. 4From: A risk analysis of alpelisib-induced hyperglycemia in patients with advanced solid tumors and breast cancerProgression-free survival for patients with PIK3CA mutations with high and low risk of hyperglycemia (model 7) treated with alpelisib in SOLAR-1Back to article page